US Patent Issued to Pfizer on Oct. 27 for "Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof" (North Carolina, New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,447, issued on Oct. 27, was assigned to Pfizer Inc. (New York).

"Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof" was invented by Avvari Krishna Prasad (Chapel Hill, N.C.), Jianxin Gu (Paramus, N.J.), Jin-Hwan Kim (Suffern, N.Y.) and Suddham Singh (Monroe, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new glycoconjugates comprising Streptococcus pneumoniae capsular saccharide antigens and uses thereof. Glycoconjugates of the present invention will typically comprise 2 or more saccharides antigens conjugated to the same molecule of the protein carrier. The invention also re...